OKYO Pharma OKYO
NASDAQ OKYO
$1.47 +0.15 (+11.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Change in Account Payables (2025 - 2026)

Updated

OKYO Pharma (OKYO) recorded Change in Account Payables of -$853,810 in the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Change in Account Payables (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma reported Change in Account Payables of $362,621, down 70.2% from the prior year.

  • Annual Change in Account Payables has a five-year compound annual growth rate of -16.4% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Change in Account Payables came in at $1.22 million in the year ended Mar 31, 2025, $2.8 million in the year ended Dec 31, 2024 (-5.5%), $2.96 million in the year ended Dec 31, 2023 and -$297,991 in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 18.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 OKYO Pharma 901.51 Mn 901.51 Mn - -853,810.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -853,810.00
Dec 31, 2025 1.86 Mn
API Access

OKYO Pharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=OKYO&period=max&api_key=YOUR_API_KEY